PLX PHARMA INC - COM (PLXPQ)

CUSIP: 72942A107

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
2,120,671
Share change
-49,515
Total reported value
$3,245,000
Price per share
$1.53
Number of holders
13
Value change
-$157,408
Number of buys
3
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 72942A107?
CUSIP 72942A107 identifies PLXPQ - PLX PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLX PHARMA INC - COM (PLXPQ) as of Q4 2018

As of 31 Dec 2018, PLX PHARMA INC - COM (PLXPQ) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,120,671 shares. The largest 10 holders included Park West Asset Management LLC, Harel Insurance Investments & Financial Services Ltd., Vanguard Group Inc, BROWN ADVISORY INC, UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, Fayez Sarofim & Co, and UBS Group AG. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.